Consequently, we conducted full dose-response cell viability assays on the library compounds, employing a panel of hematological cell lines including NCI-H929 (MM), MV-4-11(AML), and Ocl-Ly3 (DLBCL) cells. This evidence concerns the gene CD8B and Miyoshi myopathy.